Graves병 갑상선 기능항진증에서 방사성 옥소 치료의 지견 (Current Opinions on the Radioiodine Treatment of Graves Hyperthyroidism) |
Author |
이상우,이재태, |
Sang Woo Lee, M.D., Jaetae Lee, M.D. |
Affiliation |
경북대학교의과대학 핵의학교실 Department of Nuclear Medicine, Kyungpook National University School of Medicine, Daegu, Korea |
Abstract |
Radioactive iodine therapy using I-131 for hyperthyroidism has been used for more than 50 years, and
generally considered safe and devoid of major side effects. Appropriate patient selection criteria and clinical
judgement concerning patient preparation should be employed for its optimal use. It has not been possible
to resolve the trade-off between efficient definite cure of hyperthyroidism and the high incidence of
post-therapy hypothyroidism. The dose of the I-131 needed to maintain euthyroid state remains an area of
uncertainity and debate. Early side effects are uncommon and readily managable. Other than the need for
long-term monitoring and, in most cases, lifelong thyroid hormone treatment for late adverse consequences
of this treatment remains only conjectural. We have reviewed general principles and recent advances in
radioiodine treatment for Graves hyperthyroidism, specially regarding to several controversies. |
Keyword |
radioiodine treatment, Graues hyperthyroidism. |
Full text Article |
3706341.pdf
|
|
|